INTRODUCTION

CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) IS THE MOST WIDELY PRESCRIBED TREATMENT FOR OBSTRUCTIVE SLEEP APNEA (OSA).
Compliance is central to a good clinical outcome but can be problematic. Studies have reported variable compliance. [1] [2] [3] [4] [5] [6] [7] There is debate on what is deemed good compliance, 5 but most groups acknowledge that 4 or more hours of use per night will significantly improve symptoms. 2 Some have shown that up to one third of patients will eventually decline CPAP treatment. [6] [7] [8] [9] Studies on machine use have been conflicting because of variations in sample size, length of follow up, and arbitrary definitions of compliance.
Few studies have reported the influence of mood on compliance with CPAP, yet this has been shown to be important in complying with a number of other medical treatments. [11] [12] [13] [14] [15] [16] [17] [18] Edinger 19 showed that higher scores of Depression and Hypochondriasis (measured on the Minnesota Multiphasic Personality Inventory), alongside other factors, significantly contributed to poor compliance in a small group of 38 patients with OSA, followed for 6 months. This study relied on self-reported machine use, and their definition of good compliers was arbitrary. A retrospective analysis that tried to identify psychosocial determinants of CPAP use 20 concluded similarly that patients with lower anxiety scores (assessed via Nottingham Health Profile Part 2) were higher users of CPAP. Patients with OSA may have psychological problems, but Pillar 21 found that neither the existence nor the severity of OSA was associated with depression or anxiety.
Most studies looking at compliance have been retrospective and predominantly looking for physical determinants. One retrospective study applied multiple-regression analysis on data derived from a 2-week trial of CPAP to identify good compliers at 1 year. 22 Rosenthal 23 similarly found that a 1-week trial reliably identified users from nonusers at 1 year-even in a population with mild OSA; however, the distinction between consistent and inconsistent users has been found to be apparent from as early as the fourth day of treatment. 24 We would like to predict at the very onset of treatment, those subjects less likely to use their machines-and offer early interventions. The first month of treatment strongly predicts long-term use, so we prospectively examined the relationships between physical and psychosocial information that was available before issuing CPAP machines and machine on time over the first month of treatment.
METHODS
Patients
Eighty-two patients with newly diagnosed OSA and an Epworth Sleepiness Scale score (ESS) of 10 or more were approached. There is currently no objective method of determining compliance in advance, so power calculations are not possible, since subsample sizes corresponding to compliance will be random. All had a positive home-based (Synectics I and II, Synectics Medical, Stockholm, Sweden) or hospitalbased (eg, Visilab, Oakwood Scientific, Oxford, United Kingdom) sleep study with an apnea-hypopnea index (AHI) greater than 10 (the number of apneas + hypopneas per hour of sleep), a desaturation index (DI) of 10 or more (the number of SaO 2 desaturations of 4% or more per hour of sleep), or both. The sleep recordings and videos were manually reviewed. Approval was obtained from the local Research Ethics Committee, and written informed consent was obtained from participants.
Procedure
After receiving an explanation and training by the cardiorespiratory technician, patients were issued a ResMed Sullivan V or S6 CPAP machine (ResMed, Sydney, NSW, Australia) and admitted overnight for autotitration of CPAP. A semistructured interview then yielded the following 21 determinants that were tested against machine use: patient's age, sex, collar size, and body mass index (BMI); presence of facial hair, upper respiratory tract symptoms, or any known coexistent pulmonary disease; daily cigarette consumption; current alcohol intake (units per week); concurrent medication use; whether sleeping alone (or with partner); shift work; and whether they had experienced a recent (within 6 months) life event. Patients also completed the Hospital Anxiety and Depression Scale (HADS) and ESS. Finally, they were asked a closedended simple question of "Have you encountered any problems during this first night of CPAP?'' (Yes or No). A single blood pressure was recorded (digital monitor UA-767, A & D Instruments, Abingdon, Oxon, United Kingdom) by nursing staff, in the afternoon, when patients first attended for clinic evaluation. Other variables available at baseline, which may influence machine use, included the AHI, DI, and starting CPAP pressure.
Following autotitration, each patient was advised to use his or her machine every night, for as many hours as tolerable. The hourly 'ontime' clocks in the CPAP machines were hidden from the patients' view.
During a second interview, after approximately 1 month of treatment, HADS and ESS were again completed, the results were recorded, and the average nightly use of CPAP was calculated from total machine on time.
Patients not returning for the follow-up visit were contacted by telephone and then letter; if these attempts failed, the patients were deemed lost to follow up.
Statistical Analysis
We used SPSS version 11 (SPSS Inc, Chicago, Illinois, USA) for statistical analysis. For continuous variables, we calculated Pearson correlations, an appropriate summary for directly measured data, which mostly satisfies tests for normality. For categorical variables, we divided the sample into 2 subgroups according to the presence or absence of a given characteristic, and then compared the mean nightly machine 'on time' of the 2 groups, using unpaired t tests.
To assess the relationship between multiple predictor variables and machine use, we first consider Least Squares Regression, with the measured nightly average hours used as the dependent variable. With all 21 covariates available on entry, a stepwise-regression method yielded a model that predicted mean nightly machine on time as a function of the most significant categorical variables.
There is some clinical evidence that an average of 4 hours of CPAP use per night is necessary to significantly improve outcomes, 2 so we regarded a patient with an average use of at least 4 hours per night as compliant, and those with less on time as noncompliant. This categorization lost useful information from the original data, but we used logistic regression with this binary outcome as the dependent variable.
Reported P values were all 2-tailed, with a P value of < .05 deemed significant throughout.
RESULTS
Whole Group
Eighty-two consecutive patients were approached; only 2 patients refused entry, avoiding a source of (selection) bias. Initial demographic data (mean ± SD) were largely complete: age, 51 ± 10 years; BMI, 35.5 ± 6.0 kg/m 2 ; DI, 31.0 ± 22.0; AHI, 25.1 ± 23.0; and ESS score 14.4 ± 6.0. Patients were followed for a median of 31 days (range 11-121 days); follow-up time cannot be regarded as normal (Kolmorogov-Smirnov P < .001). The Anxiety score prior to treatment was 7.82 ± 3.65, with a range of 1 to 17. The mean Depression score prior to treatment was 6.02 ± 3.60, with a range of 1 to 16.
Defaulters
Ten patients did not return for the 1-month follow-up visit, and we note that 7 patients in this small but important group reported problems during autotitration. Further considerations of such defaulters are clearly worthwhile but are beyond the scope of this study because larger numbers are needed for meaningful analysis.
Attendees
Further reporting is limited to the 70 patients who had complete baseline data and returned at 1 month so that their nightly CPAP use could be reliably calculated. Data on smoking and alcohol consumption were not normal (many reported 0); therefore results were categorized (eg, smoker / nonsmoker). Most measured variables were normally distributed; AHI and blood pressure were exceptions.
For the 70 patients continuing with their CPAP treatment, the mean ± SD nightly machine on time was 4.7 ± 2.05 hours. There was a mean change in the ESS score of -5.8 (range, -22 to +6). Table 1 illustrates the correlations between continuous variables and mean hours of CPAP machine on time per night.
The correlations between mean nightly machine on time and change in ESS were r = -0.38 (P < .001); change in anxiety, r = -0.30 (P = .0.01); and change in depression, r = -0.38 (P < .001). Table 2 illustrates the numbers and differences in machine use in each subgroup (according to the presence or absence of a given variable) for the 70 patients with recorded machine use, at 1 month. Table 1 shows that no baseline variable is significantly correlated with hours of machine use. Table 2 shows the categorical variables of sex, known pulmonary disease, recent life events, initial problems, and lives alone each split the follow-up patients into subgroups with statistically significant differences in group means of nightly CPAP use. We have small numbers of women (n = 4) and patients with coexistent pulmonary disease (n = 5), and they have no appreciable effect on our predictor model. These summaries show, at best, a limited scope for building regression models for predicting hours of machine use. We considered 2 related approaches.
Regression Analysis
Least-Squares Regression
Using a stepwise regression method, with all 21 covariates available, yielded a model that predicted mean nightly machine on time as a function of the 2 most important categorical variables, Recent Life Events and Initial Problems on the first night of nCPAP; the regression model used was Hours Used = 5.465 -1.75*Life -1.88*Problems, in which the categorical variables values were 0 and 1 to denote absence and presence, respectively. The t statistics associated with the 2 regression coefficients were -3.308 (P = .002) and -3.557 (P = .001), respectively. This model quantifies the average reduction in hours used in the presence of the 2 complications. Table 3 .
Logistic Regression
Therefore, Reporting Initial Problems (after the first night of CPAP use) can identify those patients who will use their machine for less than 4 hours per night with a sensitivity of 50%, a specificity of 87%, a positive predictive value (PPV) of 73% , and a negative predictive value (NPV) of 71%; that is, those not reporting problems have a 71% probability of using their machines more than 4 hours per night.
DISCUSSION
Population Studied
Our patients were typical of those with suspected OSA who are referred to clinics. 22, 44, 49 
pulmonary physicians. Our patients had similar initial ESS scores and responses to treatment to those from patients in other sleep units. 22, 49 Use of the CPAP Machine Ten of our 80 patients were not using CPAP at 1 month, and so our continuation rate of 87.5% compares to other studies of between 65% and 83% over varying follow-up periods. 22, [25] [26] [27] [28] We expect a few more discontinuations over time, although, in general, machine use is strongly predicted by the crucial early stages. 2, 3, [29] [30] [31] [32] For those 70 patients continuing to use CPAP, the mean nightly use was 4.7 hours. Early studies relying mainly on self reporting 3,29 and visible timers 30, 31 recorded mean daily usage of 5 to 6 hours and showed that rate to be maintained over 1,000 days of follow up. 32 While using hidden timers, Kaplan et al 24 found a bimodal pattern of use (ie, either regularly with an average of 6.2 hours per night or only sporadically), but some only averaging 3.5 hours per night (P < .001) and no predictors of group membership.
Others have found variable times of mean effective nightly use (when the machine is running at the prescribed pressure). Many studies were difficult to compare, because compliance was calculated in different ways, but found that CPAP timers overestimate the actual effective compliance by only about 10%. 2, 31, 33, 34 Our final estimate of nightly use at effective pressure based on this adjustment was 4.2 hours for those who continued with the study.
Psychological Determinants of CPAP Use
Those patients who experienced a life event within 6 months of initiating the study had significantly lower CPAP use than did those who suffered no recent life events.
Our subjects' baseline Anxiety and Depression scores had a similar distribution to Zigmond's original population of medical outpatients. 37 We found that pretreatment Anxiety and Depression scores (as measured by HADS) were not correlated with machine use (eg, in the same way as inhaler use is in asthma) over the first month of treatment. Depression measured by different tools, such as the Minnesota Multiphasic Personality Inventory, is associated with lower CPAP usage, when taken alongside Hypochondriacal scores and other physical variables. 19 In a retrospective analysis, Murray et al 20 found that lower anxiety levels (as assessed by using HADS) were an independent determinant of better CPAP use at 1 to 3 months and at 1 year. They found no association with CPAP use and depression but concluded that psychosocial scores, which also included the Nottingham Health Profile (Part 2), may contribute additional power over traditional clinical and sociodemographic variables in identifying patients at risk of discontinuing CPAP use in both the short and long term. Others have found that scores on validated psychological tools have mixed abilities in predicting machine use. 38, 39 In summary, the influence of anxiety and depression on compliance in OSA treatment is less proven than in other conditions.
Side Effects of Treatment
Our patients who reported Initial Problems following the first night of CPAP use had significantly less nightly machine on time after 1 month than had those who reported no immediate problems. Of the 10 patients who did not return for the follow-up visit, 7 reported initial problems at autotitration. Those reporting initial problems at autotitration were almost 3 times as likely to use their machines for less than 4 hours per night than those not reporting problems, again confirming that this is an important discriminator. Although side effects would seem central to discontinuing treatment, they do not appear to be important in some studies [28] [29] [30] but are cited as being important in others. 2, 25, 26 One study reported that a feeling of claustrophobia, retrospectively reported after a mean of 106 days use, was the only problem identified significantly more often by patients who used their CPAP less regularly. 33 A German study showed that 'positive early subjective statements' predicted acceptance of CPAP therapy in a small group of 14 patients at 4 months. 40 We note that patients utilize medical services more regularly prior to having their OSA diagnosed and being established on CPAP therapy. 36 It is not uncommon for them to be admitted to the hospital in the preceding 6 months; such patients suffering this life event may also report problems at autotitration. There may therefore be some scope in our multipleregression model for combining the 2 original variables of Recent Life Events and Initial Problems as a Complication variable, but we did not pursue this.
Sex
Previous comparisons of machine use by men versus women have yielded conflicting results. 9, 24, 27, [41] [42] We found that men had significantly more nightly machine on time, but more research is needed. Our own conclusions are subject to the usual caveats because of the very low number of women included in the study.
Life Events
Those who had experienced a major life event (eg, death of a spouse, hospital admission) still used their machine for an average of 3.1 hours per night, but this amount was significantly less than the use time of those who had not experienced any life event. It is likely that life events have a direct adverse effect on machine use due to concurrent stress and was important in our multiple-regression analysis. Perhaps a trial of CPAP could be postponed for a short while (eg, at least 6 months) or extra support offered if the patient has undergone any recent emotional upset. The machine use in this group may improve over time.
Other Sociodemographic Variables and Machine Use
Previous studies have found that marital status 27 or the presence of a housemate 24 did not alter patterns of CPAP use. We found that those subjects who live alone used their machines significantly less than did those who lived with a partner. We believe that the influence of the partner on machine use has been underrated and that living with someone else may encourage regular use. Like others, 2,9,24,26,27 we found that age was not correlated with machine on time. Sin et al found that CPAP was used more by older patients 42 , but others 10, 34 have found that older patients used their machines less. The effect of age on compliance has yet to be determined. There may even be a bimodal distribution, with the youngest and oldest being poor compliers.
We (unlike others 41 ) found that cigarette smoking, alcohol intake, concurrent medication use, work patterns, and presence of facial hair were not important predictors of CPAP use. Some 32, 43 have found a positive correlation between initial BMI and compliance, but, like most others, 6, 9, 24 we found that neither BMI nor collar size was associated with machine use.
The CPAP pressure was not correlated with machine use in our cohort. Although frequently mentioned by patients as being problematic, there is no conclusive evidence that higher pressures of CPAP limit compliance. 24, 30, 32 Autotitrating CPAP machines have been effective at significantly lowering mean CPAP pressures and still maintaining arterial oxygenation 44 but have no significant advantages in patient tolerance, compliance, or daytime sleepiness above those found with the use of standard CPAP, 45 despite increased cost.
Physiologic Severity of OSA
We found no correlation between any of the measurements of nocturnal respiratory disturbance and machine on-time. Most researchers have found no difference between good compliers and poor compliers in baseline AHI and polysomnography at presentation. 2, 9, 24, 25, 28, 35 Those who have found statistically significant correlations could explain only 4% of the variance in machine use and so concluded that initial AHI was not clinically important in determining machine use. 36 A few have reported that compliance is greater in those with a higher initial AHI or DI. 10, 30, 41 The general consensus is that the results of initial sleep studies do not predict use of CPAP.
Symptomatic Severity of OSA
There was no correlation between ESS score and machine use. We feel that the self-reported propensity to fall asleep is unreliable in identifying those who will use their machine appropriately. Some have found that worse initial symptoms of excessive daytime sleepiness are associated with greater CPAP use, 28, 33, 35, 41 but the majority of studies have found no difference in initial sleep-latency tests or self-reported initial sleepiness between eventual good compliers and poor compliers. 2, 4, 8, 30 Response to Treatment For those 70 patients who continued with CPAP, we found an improvement in ESS score that was statistically significant (P < .001); with a mean fall of 5.8 points, this is likely to be clinically important and unlikely to be a placebo effect. Engelman et al 47 showed a similar mean fall in ESS score of 6 units in a well-designed trial.
Our groups' reduction in ESS score was significantly correlated to machine use, with the biggest improvements in subjective sleepiness occurring, on average, in those who used their machines the most. A Polish group found almost the same correlation (r = 0.4, P < .001) between reduction in ESS score and CPAP compliance. 49 They followed fewer patients but for a longer period of time-more than 1 year. Others have also found that good compliance strongly correlated with the differences in ESS scores 42 and hypersomnia scores, 30 and regular users reported having improved levels of daytime energy and greater satisfaction with CPAP. 2, 10, 25, 33 The change (reduction) in Hospital Anxiety and Depression scores was strongly correlated with machine use, but this does not prove a causal relationship, and because a repeat appointment was needed to document any change, these are also of no use as baseline predictors.
This was a prospective study, but potential limitations include the low number of women and ethnic minorities. Our group consisted of unselected consecutive subjects and reflected local demographics and referral patterns. We had a very variable length of follow up (22-110 days), which we believe reflects the large geographic area that we serve and the ensuing difficulties that patients encounter in traveling large distances on set dates. A subgroup analysis of only those patients followed for 25 to 31 days (n = 64) did not alter any allocation of statistical significance and did not change our conclusions.
We believe that our patients were unaware of the timers. All clock covers were intact at review. No subject mentioned the clocks. They were not told that the machines could monitor usage but that we would be looking at general 'progress' at 1 month. Because many timers were not reset to zero, when first issued, patients would be less likely to realize the significance of changing digital numbers-even if they did remove and then replace the covers.
Sleep physicians, in general, have researched compliance issues extensively, but most studies are retrospective and few take into account early subjective reports from patients and psychologic measures. Early predictors are even more important when there is evidence that any effect of intervention is stronger when introduced during the first month of CPAP therapy. 48 The typical nightly use for a person without initial problems is almost 5 hours; it is less than half that (in fact, 2.4 hours) for a person who experiences initial problems.
Although the HADS score was not associated with machine use, the data recording the presence or absence of patients' early problems, recent life events and whether they live alone do seem to be important in predicting use. These variables can be identified before issuing a CPAP machine on day 1, and it should be worthwhile in providing extra information or instruction to those patients at highest risk of CPAP failure.
